1. Home
  2. LMFA vs AYTU Comparison

LMFA vs AYTU Comparison

Compare LMFA & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMFA
  • AYTU
  • Stock Information
  • Founded
  • LMFA 2008
  • AYTU N/A
  • Country
  • LMFA United States
  • AYTU United States
  • Employees
  • LMFA N/A
  • AYTU N/A
  • Industry
  • LMFA Finance: Consumer Services
  • AYTU Biotechnology: Pharmaceutical Preparations
  • Sector
  • LMFA Finance
  • AYTU Health Care
  • Exchange
  • LMFA Nasdaq
  • AYTU Nasdaq
  • Market Cap
  • LMFA 9.2M
  • AYTU 9.8M
  • IPO Year
  • LMFA 2015
  • AYTU N/A
  • Fundamental
  • Price
  • LMFA $2.28
  • AYTU $1.41
  • Analyst Decision
  • LMFA Hold
  • AYTU
  • Analyst Count
  • LMFA 1
  • AYTU 0
  • Target Price
  • LMFA N/A
  • AYTU N/A
  • AVG Volume (30 Days)
  • LMFA 149.6K
  • AYTU 36.9K
  • Earning Date
  • LMFA 11-13-2024
  • AYTU 02-12-2025
  • Dividend Yield
  • LMFA N/A
  • AYTU N/A
  • EPS Growth
  • LMFA N/A
  • AYTU N/A
  • EPS
  • LMFA N/A
  • AYTU N/A
  • Revenue
  • LMFA $12,838,084.00
  • AYTU $79,759,000.00
  • Revenue This Year
  • LMFA N/A
  • AYTU N/A
  • Revenue Next Year
  • LMFA N/A
  • AYTU N/A
  • P/E Ratio
  • LMFA N/A
  • AYTU N/A
  • Revenue Growth
  • LMFA 27.81
  • AYTU N/A
  • 52 Week Low
  • LMFA $2.18
  • AYTU $1.30
  • 52 Week High
  • LMFA $6.11
  • AYTU $3.45
  • Technical
  • Relative Strength Index (RSI)
  • LMFA 34.52
  • AYTU 34.74
  • Support Level
  • LMFA $2.67
  • AYTU $1.38
  • Resistance Level
  • LMFA $2.90
  • AYTU $1.70
  • Average True Range (ATR)
  • LMFA 0.25
  • AYTU 0.11
  • MACD
  • LMFA -0.06
  • AYTU -0.00
  • Stochastic Oscillator
  • LMFA 8.49
  • AYTU 16.22

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

Share on Social Networks: